These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18508689)

  • 1. Role of Toll like receptor signaling pathway in ischemic coronary artery disease.
    Satoh M; Ishikawa Y; Minami Y; Takahashi Y; Nakamura M
    Front Biosci; 2008 May; 13():6708-15. PubMed ID: 18508689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Toll-like receptor mediated signaling pathway in ischemic heart.
    Takeishi Y; Kubota I
    Front Biosci (Landmark Ed); 2009 Jan; 14(7):2553-8. PubMed ID: 19273219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart.
    Chao W
    Am J Physiol Heart Circ Physiol; 2009 Jan; 296(1):H1-12. PubMed ID: 19011041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor signaling in the ischemic heart.
    Frantz S; Ertl G; Bauersachs J
    Front Biosci; 2008 May; 13():5772-9. PubMed ID: 18508620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR4 signaling: a potential therapeutic target in ischemic coronary artery disease.
    Jia SJ; Niu PP; Cong JZ; Zhang BK; Zhao M
    Int Immunopharmacol; 2014 Nov; 23(1):54-9. PubMed ID: 25158302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptors: link between "danger" ligands and plaque instability.
    Balogh S; Kiss I; Csaszar A
    Curr Drug Targets; 2009 Jun; 10(6):513-8. PubMed ID: 19519353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLRs are important inflammatory factors in atherosclerosis and may be a therapeutic target.
    Liu Y; Yu H; Zhang Y; Zhao Y
    Med Hypotheses; 2008; 70(2):314-6. PubMed ID: 17689203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptors: new therapeutic targets for the treatment of atherosclerosis, acute coronary syndromes, and myocardial failure.
    Erickson B; Sperber K; Frishman WH
    Cardiol Rev; 2008; 16(6):273-9. PubMed ID: 18923230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research Progress of Mechanisms and Drug Therapy For Atherosclerosis on Toll-Like Receptor Pathway.
    Yin QY; Zhao B; Qiu YY; Fei YX; Hu YH; Li YM
    J Cardiovasc Pharmacol; 2019 Nov; 74(5):379-388. PubMed ID: 31730559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral-blood gene expression profiling studies for coronary artery disease and its severity in Xinjiang population in China.
    Liu M; Jiang S; Ma Y; Ma J; Hassan W; Shang J
    Lipids Health Dis; 2018 Jul; 17(1):154. PubMed ID: 30021655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global TLR2 and 4 deficiency in mice impacts bone resorption, inflammatory markers and atherosclerosis to polymicrobial infection.
    Chukkapalli SS; Velsko IM; Rivera-Kweh MF; Larjava H; Lucas AR; Kesavalu L
    Mol Oral Microbiol; 2017 Jun; 32(3):211-225. PubMed ID: 27224005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging coronary artery disease and the myocardial ischemic cascade: clinical principles and scope.
    Renker M; Baumann S; Rier J; Ebersberger U; Fuller SR; Batalis NI; Schoepf UJ; Chiaramida SA
    Radiol Clin North Am; 2015 Mar; 53(2):261-9. PubMed ID: 25726992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherosclerosis: current pathogenesis and therapeutic options.
    Weber C; Noels H
    Nat Med; 2011 Nov; 17(11):1410-22. PubMed ID: 22064431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 4 stimulation initiates an inflammatory response that decreases cardiomyocyte contractility.
    Avlas O; Fallach R; Shainberg A; Porat E; Hochhauser E
    Antioxid Redox Signal; 2011 Oct; 15(7):1895-909. PubMed ID: 21126202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of genetic polymorphisms of TLR2 and TLR4 in Turkish patients with coronary artery disease.
    Guven M; Ismailoglu Z; Batar B; Unal S; Onaran I; Karadag B; Ongen Z
    Gene; 2015 Mar; 558(1):99-102. PubMed ID: 25542811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel immune signals and atherosclerosis.
    Iwata H; Nagai R
    Curr Atheroscler Rep; 2012 Oct; 14(5):484-90. PubMed ID: 22864646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptors mediating vascular malfunction: Lessons from receptor subtypes.
    Wang Y; Song E; Bai B; Vanhoutte PM
    Pharmacol Ther; 2016 Feb; 158():91-100. PubMed ID: 26702901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease.
    Moreira DM; da Silva RL; Vieira JL; Fattah T; Lueneberg ME; Gottschall CA
    Am J Cardiovasc Drugs; 2015 Feb; 15(1):1-11. PubMed ID: 25369900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptors: sensing and reacting to diabetic injury in the kidney.
    Lin M; Tang SC
    Nephrol Dial Transplant; 2014 Apr; 29(4):746-54. PubMed ID: 24203812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptors in angiogenesis.
    Grote K; Schütt H; Schieffer B
    ScientificWorldJournal; 2011 Apr; 11():981-91. PubMed ID: 21516292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.